195 related articles for article (PubMed ID: 38023992)
21. The clinical impact of COVID-19 on patients with cancer in British Columbia: An observational study.
Mathews AS; Paul A; Yu IS; McGahan C; Bhang E; Villa D; Gelmon K; Avina-Zubieta A; Gerrie AS; Lee U; Chia S; Woods RR; Loree JM
Heliyon; 2022 Dec; 8(12):e12140. PubMed ID: 36506364
[TBL] [Abstract][Full Text] [Related]
22. Modelling of hypothetical SARS-CoV-2 point-of-care tests on admission to hospital from A&E: rapid cost-effectiveness analysis.
Stevenson M; Metry A; Messenger M
Health Technol Assess; 2021 Mar; 25(21):1-68. PubMed ID: 33764295
[TBL] [Abstract][Full Text] [Related]
23. Severe acute respiratory syndrome coronavirus 2 vaccination for patients with solid cancer: Review and point of view of a French oncology intergroup (GCO, TNCD, UNICANCER).
Tougeron D; Hentzien M; Seitz-Polski B; Bani-Sadr F; Bourhis J; Ducreux M; Gaujoux S; Gorphe P; Guiu B; Hoang-Xuan K; Huguet F; Lecomte T; Lièvre A; Louvet C; Maggiori L; Mansi L; Mariani P; Michel P; Servettaz A; Thariat J; Westeel V; Aparicio T; Blay JY; Bouché O; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
Eur J Cancer; 2021 Jun; 150():232-239. PubMed ID: 33934060
[TBL] [Abstract][Full Text] [Related]
24. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.
Wiersinga WJ; Rhodes A; Cheng AC; Peacock SJ; Prescott HC
JAMA; 2020 Aug; 324(8):782-793. PubMed ID: 32648899
[TBL] [Abstract][Full Text] [Related]
25. Seroprevalence and immunological memory against SARS-CoV-2 in lung cancer patients: the SOLID study.
Provencio M; Rodríguez-Abreu D; Ortega AL; Serrano G; Aguado C; Franco F; Gutierrez V; López Vivanco G; Guirado M; Benítez G; Estival A; Calvo V; Jiménez B; Arasanz H; Coves J; Majem M; Massutí B; Vázquez S; Juan-Vidal O; Collazo-Lorduy A; Gozálvez CL; Del Barco E; Rosero A; Bosch-Barrerra J; Moreno MA; Mielgo-Rubio X; Villa JC; López-Martin A; Córdoba JF; de Asís Aparisi F; Zafra M; Mosquera J; Pérez Altozano J; Nadal E; Catot S; Balsalobre J; de Portugal T; Martín P; Cuesta de Juan S; Cobo M
Transl Lung Cancer Res; 2022 Jan; 11(1):53-63. PubMed ID: 35242627
[TBL] [Abstract][Full Text] [Related]
26. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
27. COVID-19 and pulmonary tuberculosis - A diagnostic dilemma.
Biswas SS; Awal SS; Awal SK
Radiol Case Rep; 2021 Nov; 16(11):3255-3259. PubMed ID: 34367387
[TBL] [Abstract][Full Text] [Related]
28. Cancer and SARS-CoV-2 Infection: A Third-Level Hospital Experience.
Calvo V; Fernandez-Cruz A; Nuñez B; Blanco M; Morito A; Martínez M; Traseira C; Garitaonaindía Y; Aguado R; Ramos A; Royuela A; Franco FF; Provencio M
Clin Epidemiol; 2021; 13():317-324. PubMed ID: 34040447
[TBL] [Abstract][Full Text] [Related]
29. A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group.
Al-Shamsi HO; Alhazzani W; Alhuraiji A; Coomes EA; Chemaly RF; Almuhanna M; Wolff RA; Ibrahim NK; Chua MLK; Hotte SJ; Meyers BM; Elfiki T; Curigliano G; Eng C; Grothey A; Xie C
Oncologist; 2020 Jun; 25(6):e936-e945. PubMed ID: 32243668
[TBL] [Abstract][Full Text] [Related]
30. Characterization of COVID-19 disease in pediatric oncology patients: The New York-New Jersey regional experience.
Madhusoodhan PP; Pierro J; Musante J; Kothari P; Gampel B; Appel B; Levy A; Tal A; Hogan L; Sharma A; Feinberg S; Kahn A; Pinchinat A; Bhatla T; Glasser CL; Satwani P; Raetz EA; Onel K; Carroll WL
Pediatr Blood Cancer; 2021 Mar; 68(3):e28843. PubMed ID: 33338306
[TBL] [Abstract][Full Text] [Related]
31. Acute respiratory distress syndrome (ARDS) caused by the novel coronavirus disease (COVID-19): a practical comprehensive literature review.
Montenegro F; Unigarro L; Paredes G; Moya T; Romero A; Torres L; López JC; González FEJ; Del Pozo G; López-Cortés A; Diaz AM; Vasconez E; Cevallos-Robalino D; Lister A; Ortiz-Prado E
Expert Rev Respir Med; 2021 Feb; 15(2):183-195. PubMed ID: 32902367
[TBL] [Abstract][Full Text] [Related]
32. Severe acute respiratory syndrome coronavirus-2 Alpha variant (B.1.1.7), original wild-type severe acute respiratory syndrome coronavirus 2, and cytomegalovirus co-infection in a young adult with acute lymphoblastic leukemia, case report, and review of the possible cytomegalovirus reactivation mechanisms.
Amanati A; Shahriari M; Bordbar MR; Hedayati SB; Ziyaeyan M; Jamalidoust M; Kalani M; Heydari Marandi N
J Med Case Rep; 2023 Feb; 17(1):66. PubMed ID: 36765433
[TBL] [Abstract][Full Text] [Related]
33. Lung Cancer and Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Identifying Important Knowledge Gaps for Investigation.
Rolfo C; Meshulami N; Russo A; Krammer F; García-Sastre A; Mack PC; Gomez JE; Bhardwaj N; Benyounes A; Sirera R; Moore A; Rohs N; Henschke CI; Yankelevitz D; King J; Shyr Y; Bunn PA; Minna JD; Hirsch FR
J Thorac Oncol; 2022 Feb; 17(2):214-227. PubMed ID: 34774792
[TBL] [Abstract][Full Text] [Related]
34. Impact of the COVID-19 Pandemic on Colorectal Cancer Diagnosis and Treatment: a Systematic Review.
Mazidimoradi A; Hadavandsiri F; Momenimovahed Z; Salehiniya H
J Gastrointest Cancer; 2023 Mar; 54(1):171-187. PubMed ID: 34843058
[TBL] [Abstract][Full Text] [Related]
35. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.
Piechotta V; Iannizzi C; Chai KL; Valk SJ; Kimber C; Dorando E; Monsef I; Wood EM; Lamikanra AA; Roberts DJ; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
Cochrane Database Syst Rev; 2021 May; 5(5):CD013600. PubMed ID: 34013969
[TBL] [Abstract][Full Text] [Related]
36. Biochemical parameters and pathogenesis of SARS-CoV-2 infection in vital organs: COVID-19 outbreak in Iran.
Mirmohammadi S; Kianmehr A; Arefi M; Mahrooz A
New Microbes New Infect; 2020 Nov; 38():100792. PubMed ID: 33101694
[TBL] [Abstract][Full Text] [Related]
37. Mobility as a driver of severe acute respiratory syndrome coronavirus 2 in cancer patients during the second coronavirus disease 2019 pandemic wave.
Fong D; Mair MJ; Lanthaler F; Alber M; Mitterer M
Int J Cancer; 2022 Feb; 150(3):431-439. PubMed ID: 34610144
[TBL] [Abstract][Full Text] [Related]
38. Radiological Society of North America (RSNA) Expert Consensus Statement Related to Chest CT Findings in COVID-19 Versus CO-RADS: Comparison of Reporting System Performance Among Chest Radiologists and End-User Preference.
O' Neill SB; Byrne D; Müller NL; Jalal S; Parker W; Nicolaou S; Bilawich AM
Can Assoc Radiol J; 2021 Nov; 72(4):806-813. PubMed ID: 33138634
[TBL] [Abstract][Full Text] [Related]
39. Thoracic imaging tests for the diagnosis of COVID-19.
Salameh JP; Leeflang MM; Hooft L; Islam N; McGrath TA; van der Pol CB; Frank RA; Prager R; Hare SS; Dennie C; Spijker R; Deeks JJ; Dinnes J; Jenniskens K; Korevaar DA; Cohen JF; Van den Bruel A; Takwoingi Y; van de Wijgert J; Damen JA; Wang J; ; McInnes MD
Cochrane Database Syst Rev; 2020 Sep; 9():CD013639. PubMed ID: 32997361
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
